2017
Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004–2014
Sharma P, McCarty TR, Njei B. Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004–2014. Obesity Surgery 2017, 28: 1015-1024. PMID: 29047047, DOI: 10.1007/s11695-017-2959-0.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBariatric SurgeryDatabases, FactualFemaleHospital CostsHospital MortalityHospitalizationHumansIncidenceInflammatory Bowel DiseasesInpatientsMaleMiddle AgedMorbidityObesity, MorbidPostoperative ComplicationsPrognosisTreatment OutcomeUnited StatesYoung AdultConceptsInflammatory bowel diseaseIncidence risk ratioObese IBD patientsBariatric surgeryMorbid obesityIBD patientsRenal failureBowel diseaseClinical outcomesUnited States National Inpatient Sample (NIS) databaseNational Inpatient Sample databaseOutcomes of patientsLength of stayPaucity of dataHospital mortalityThromboembolic eventsObese patientsSecondary outcomesHospitalized patientsPrimary outcomeMultivariable analysisDischarge diagnosisFistula formationHospitalization costsRisk ratioSurvival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver disease
Wong CR, Njei B, Nguyen MH, Nguyen A, Lim JK. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2017, 46: 1061-1069. PMID: 28960360, DOI: 10.1111/apt.14342.Peer-Reviewed Original ResearchConceptsNon-alcoholic fatty liver diseaseFatty liver diseaseLarger tumor sizeLiver diseaseHCC etiologyCurative intentNAFLD-HCCCurative treatmentTumor sizeMetastatic HCCCardiovascular diseaseHepatocellular carcinomaDecompensated liver diseaseWorse median survivalAbsence of cirrhosisSignificant survival differenceDiagnosis of HCCLess cirrhosisNAFLD groupMedian survivalWorse survivalFavorable survivalIndependent predictorsLiver cirrhosisHCC groupEarly transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding
Njei B, McCarty TR, Laine L. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding. Journal Of Gastroenterology And Hepatology 2017, 32: 852-858. PMID: 27624167, PMCID: PMC5350067, DOI: 10.1111/jgh.13593.Peer-Reviewed Original ResearchConceptsEarly transjugular intrahepatic portosystemic shuntTransjugular intrahepatic portosystemic shuntAcute esophageal variceal bleedingEsophageal variceal bleedingIntrahepatic portosystemic shuntVariceal bleedingUS patientsPortosystemic shuntNationwide Inpatient Sample databaseHospital mortality rateUS clinical practiceDays of hospitalizationFurther bleedingHospital deathRecurrent bleedingEndoscopic therapyInpatient mortalityPreventive therapySecondary outcomesHepatic encephalopathyPrimary outcomeHigh riskHospital reductionMortality ratePatients
2014
Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding-a nationwide study
Venkatesh PG, Njei B, Sanaka MR, Navaneethan U. Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding-a nationwide study. International Journal Of Colorectal Disease 2014, 29: 953-960. PMID: 24913253, PMCID: PMC4823646, DOI: 10.1007/s00384-014-1915-x.Peer-Reviewed Original ResearchConceptsLower gastrointestinal bleedingOutcomes of patientsYears of ageMortality rateGastrointestinal bleedingPrevalence of comorbiditiesRisk of comorbiditiesNumber of comorbiditiesPrimary discharge diagnosisCongestive heart failureImpact of comorbiditiesClinical Modification codesHealth care utilizationIdentification of comorbiditiesRisk of mortalityRisk-adjustment toolLogistic regression modelsHospital mortalityMore comorbiditiesComorbid illnessesElixhauser indexHospital stayRenal failureHeart failureOverall mortality